PVF in Decongestion of Heart Failure
- Conditions
- Heart Failure，Congestive
- Interventions
- Device: ultrasound
- Registration Number
- NCT05227872
- Lead Sponsor
- Assiut University
- Brief Summary
Evaluate PVF alterations in patients with ADHF at arrival and after decongestive treatment
- Detailed Description
Hospitalizations from heart failure have been shown to be preceded by a gradual increase in cardiac filling pressures using invasive ambulatory monitoring measurements \[1, 2\]., this technique does not directly assess congestion. The use of point-of-care ultrasound (POCUS) to evaluate lung congestion has been shown to decrease decompensations and urgent heart failure visits \[3, 4\]. However, besides lung congestion, the abdominal compartment contributes significantly to deranged cardiac as well as renal function in congestive heart failure (CHF) \[5\].There is increasing recognition that worsening renal function in CHF is related to altered renal blood flow \[6, 7\]. Recently, alterations in renal venous flow (IRVF) assessed by Doppler imaging have been associated with worse outcomes in patients with CHF \[8, 9\]. Besides IRVF alterations, portal vein flow (PVF) alterations have been proposed as a marker of venous congestion and right ventricular dysfunction \[10, 11\]. PVF and IRVF alterations have been shown to correlate with each other and were independently associated with the development of subsequent acute kidney injury (AKI) in patients undergoing cardiac surgery \[12, 13\]. Portal vein (PV) Doppler is easily obtainable and less time consuming than intra renal venous Doppler. Given the potential usefulness of evaluating venous congestion via POCUS of PVF, we decided to study the dynamic changes that occur during decongestion in patients presenting with heart failure to the emergency department Optimal method for noninvasive assessment of venous congestion remains an unresolved issue. Portal vein (PV) and intra renal venous flow alterations are markers of abdominal venous congestion and have been associated with acute kidney injury (AKI) in cardiac surgery patients. It is currently unknown if portal vein flow (PVF) alterations in heart failure can be reversed with diuretic treatment and track decongestion
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Age above 18 years.
- Patients presented with acute decompensated heart failure (either de novo HF or chronic decompensated HF) fulfilling the following criteria: new or worsening HF symptoms (including dyspnea, decreased exercise capacity, fatigue, or other volume overload symptoms), physical examination findings compatible with HF (peripheral edema, pulmonary congestion, increased jugular venous pressure or third heart sound)
- age below 18.
- pregnant.
- cardiogenic shock, or hemodynamic instability.
- Patients with previously diagnosed Child-Pugh B or C liver cirrhosis, liver transplant, or ESRD on renal replacement therapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Decompensated HF ultrasound - Compensated HF ultrasound -
- Primary Outcome Measures
Name Time Method Portal vein in mm in patients with acute decmpensated heart failure Baseline determine the portal vein flow alteration in mm in patients with acute decompensated heart failure and in patients with cardio renal syndrome
- Secondary Outcome Measures
Name Time Method Differences in portal vein flow in mm in patients with acute decompensated heart failure and compensated HF in cardiorenal syndrome Baseline Determine the differences between portal vein flow in mm in patients with acute decmpensated heart failure and those with compensated heart failure in patients with cardio renal syndrome
Trial Locations
- Locations (1)
Assiut University
🇪🇬Assiut, Egypt